Claris gets USFDA supplemental nod for Fluconazole injection
"The company has received the supplemental Abbreviated New Drug Application (ANDA) for Fluconazole injection in the US," Claris Lifesciences said in a filing to the BSE.
Apr 21, 2015, 13:53 PM IST